HIGHLIGHTS
- who: Commentary and colleagues from the University of Technology Sydney, NSW, Australia have published the paper: miRNA nanotherapeutics: potential and challenges in respiratory disorders, in the Journal: (JOURNAL)
SUMMARY
Globally, approximately around 4 million people die annually prematurely due to chronic respiratory diseases. miRNAs are small noncoding RNA molecules that are used to suppress protein translation to modulate gene_expression. Alterations in miRNA abundance can be observed both in the lung tissue and in the inflammatory cells, as regulators of the disease. miRNAs are therefore considered as potential biomarkers and new therapeutic targets for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.